Table 1 Patient characteristics by level of continuity of care.
Variable | High COC group (n = 127,238) | Low COC group (n = 109,248) | p-value | |
|---|---|---|---|---|
General characteristics | ||||
Sex | Women | 65,778 (51.70) | 63,502 (58.13) | < 0.001 |
Men | 61,460 (48.30) | 45,746 (41.87) | ||
Age | Median (IQR) | 50 (42–58) | 51 (44–59) | < 0.001 |
Mean ± SD | 49.87 ± 12.41 | 51.27 ± 11.65 | ||
≥ 65 years | 15,500 (12.18) | 14,508 (13.28) | < 0.001 | |
Insurance contributionsa | High | 58,746 (46.17) | 49,443 (45.26) | < 0.001 |
Moderate | 36,809 (28.93) | 30,921 (28.30) | ||
Low | 24,660 (19.38) | 22,084 (20.21) | ||
Payer | NHI | 121,803 (95.73) | 104,059 (95.25) | < 0.001 |
MAid | 5,435 (4.27) | 5,189 (4.75) | ||
Urbanization level of residenceb | Large urban | 63,655 (50.03) | 54,045 (49.47) | < 0.001 |
Small urban | 53,151 (41.77) | 44,820 (41.03) | ||
Rural | 10,310 (8.10) | 10,262 (9.39) | ||
Elixhauser comorbidity index | Median (IQR) | 1 (0–2) | 1 (0–2) | 0.110 |
0 | 56,976 (44.78) | 48,755 (44.63) | < 0.001 | |
1 | 38,029 (29.89) | 32,617 (29.86) | ||
2 | 20,122 (15.81) | 16,857 (15.43) | ||
3 + | 12,111 (9.52) | 11,019 (10.09) | ||
Comorbidity | Diabetes mellitus | 19,350 (15.21) | 12,875 (11.79) | < 0.001 |
None | 107,888 (84.79) | 96,373 (88.21) | ||
Antihyperlipidemic agent use | Yes | 38,484 (30.25) | 34,962 (32.00) | < 0.001 |
No | 88,754 (69.75) | 74,286 (68.00) | ||
Health services utilization for all diseases (annual average during the exposure period) | ||||
Ambulatory visits | Median (IQR) | 16.33 (10.33–25.67) | 19 (11.67–30.00) | < 0.001 |
Mean ± SD | 20.91 ± 18.19 | 24.36 ± 20.93 | ||
4–8 | 51,954 (40.83) | 50,175 (45.93) | < 0.001 | |
9–14 | 27,105 (21.30) | 24,418 (22.35) | ||
15–23 | 21,648 (17.01) | 19,137 (17.52) | ||
24 + | 26,531 (20.85) | 15,518 (14.20) | ||
Pharmacy visits | Median (IQR) | 13.33 (8.33–20.33) | 14.67 (9.33–22.67) | < 0.001 |
Mean ± SD | 15.83 ± 11.55 | 17.77 ± 12.95 | ||
Annual average all medical costs (1000 KRW)c | Overall, median (IQR) | 1119 (654–1810) | 1200 (714–2002) | < 0.001 |
Public expenditure | 762 (440–1263) | 820 (481–1411) | < 0.001 | |
Out-of-pocket payment | 327 (181–533) | 349 (200–574) | < 0.001 | |
Overall, mean ± SD | 1566 ± 2182 | 1732 ± 2229 | ||
Public expenditure | 1147 ± 1917 | 1275 ± 1915 | ||
Out-of-pocket payment | 417 ± 388 | 454 ± 427 | ||